Table 2.
Highlighted associations between common variants and opioid response.
| Opioids | Outcome | Sex | rsID | Gene | Major | Minor | MAFa | Effect | Direction | P value | Q value | CAVA impact |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Codeine/Tramadol | Poor pain control | Male | rs1056837 | CYP1B1 | G | A | 0.433 | Synonymous | Risk | 7.8 × 10−6 | 0.0076 | Low |
| rs1056836 | CYP1B1 | G | C | 0.432 | Missense | Risk | 8.0 × 10−6 | 0.0076 | Moderate | |||
| Hydrocodone/Oxycodone | Poor pain control | All | rs76026520 | MACROD2 | A | G | 0.094 | Intronic | Protective | 2.1 × 10−5 | 0.0397 | Low |
| Adverse events | All | rs35742686 | CYP2D6 | CT | C | 0.019 | Nonsense | Protective | 7.6 × 10−5 | 0.1436 | High |
aMAF empirical to the current dataset.